Research overview
A general overview of single-, dual-, and triple-receptor incretin agonists represented by semaglutide, tirzepatide, and retatrutide.
About this category
Incretin receptor agonist research examines agents that engage GLP-1 and related metabolic signalling pathways. The category includes established medicines as well as investigational agents, so evidence and regulatory status differ between them.
Select a research profile to explore mechanisms, clinical evidence, safety, comparisons, and regulatory context.
Explore the category
Select a research profile to explore its scientific context and key areas of research.
Research profile · 01
Explore semaglutide research, including GLP-1 receptor pharmacology, clinical evidence, outcomes, safety, and regulation.
Research profile · 02
Explore tirzepatide research, including dual-receptor pharmacology, clinical evidence, outcomes, safety, and regulation.
Research profile · 03
Explore retatrutide research, including triple-receptor agonism, clinical evidence, safety, stability, and regulation.
Research and educational information only. This library does not provide medical advice, dosing, administration, or treatment guidance.
